Summit enters technology license agreement with Bristol-Myers Squibb
11 September 2012 | By Peckwater PR
Summit has entered a technology license agreement with Bristol-Myers Squibb Company...
List view / Grid view
News
Sanofi Pasteur announces publication in The Lancet of world’s first efficacy results for its dengue vaccine candidate
11 September 2012 | By Sanofi Pasteur
“The complexity of dengue virus infection has hampered vaccine research for decades..."
Merck announces new Phase III data for suvorexant, an investigational insomnia medicine
10 September 2012 | By Merck
Merck remains on target to file a New Drug Application with the FDA in 2012...
Boehringer Ingelheim implements flexible fully disposable up- and downstream manufacturing
10 September 2012 | By Boehringer Ingelheim
Boehringer Ingelheim has developed and now implemented a flexible set-up...
Amgen names Ray Jordan Senior Vice President, Corporate Affairs
10 September 2012 | By Amgen
Amgen announced the appointment of Ray Jordan to the new position of senior vice president, Corporate Affairs...
Biogen Idec sells BENLYSTA royalty rights to DRI Capital managed fund
10 September 2012 | By Biogen Idec
Biogen Idec has sold to a DRI Capital managed fund its royalty and other rights relating to BENLYSTA®...
Lilly announces results from lung cancer study
6 September 2012 | By Eli Lilly and Company
The Phase III POINTBREAK trial did not meet its primary endpoint...
Boehringer Ingelheim and the ETH Zurich announce diabetes and obesity research collaboration
6 September 2012 | By Boehringer Ingelheim
The joint effort will focus on investigating three cell types...
Abbott to collaborate with Astellas in CMV Vaccine Trial
6 September 2012 | By Abbott
Abbott has signed an agreement to collaborate with Astellas Pharma Global Development...
New data for Novartis drug Lucentis® confirms long-term efficacy and safety profile and benefits of individualized treatment
5 September 2012 | By Novartis
New data for Lucentis®...
Roche committed to innovation and growth
5 September 2012 | By Roche
Personalised healthcare leadership and world-class pipeline presented at investor conference...
Pfizer receives EU Marketing Authorization for INLYTA®(Axitinib)
4 September 2012 | By Pfizer
The European Commission has granted marketing authorization for INLYTA® (axitinib)...
Lilly Diabetes launches mobile application for those who support people with Type 1 diabetes
4 September 2012 | By Eli Lilly and Company
Lilly Diabetes launches Lilly Glucagon Mobile App to support #diabetes caregivers...
Tecan and Siloam Biosciences co-market new ELISA system
Tecan and Siloam Biosciences Inc. announce their intent to co-market a new automated low volume, high sensitivity microfluidic ELISA...
U.S. Food and Drug Administration approves BOSULIF® (bosutinib)
4 September 2012 | By Pfizer
“BOSULIF is the third new medicine to be approved by the FDA in just 13 months..."
